SurgePays Stock Forecast, Price & News

Wall Street analysts have given SurgePays a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SurgePays wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SurgePays, Inc. (NASDAQ:SURG) issued its quarterly earnings data on Wednesday, October, 14th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, meeting the Thomson Reuters' consensus estimate of $0.06.
View SurgePays' earnings history.

SurgePays' stock was trading at $0.2965 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SURG shares have decreased by 59.5% and is now trading at $0.12.
View which stocks have been most impacted by COVID-19.

Some companies that are related to SurgePays include 21512 (SAT.L) (SAT), 5G Networks (5GN), Altice Europe (ALLVF), Altice Europe (ALTCY), América Móvil (AMOV), Aussie Broadband (ABB), Axiata Group Berhad (AXXTF), Beam Communications (BCC), Bezeq The Israel Telecommunication (BZQIY), Bezeq The Israel Telecommunication (BZQIF), BT Group (BTGOF), Cellnex Telecom (CLLNY), China Tower (CHWRF), Cogeco Communications (CGEAF) and Cogeco (CGECF).
View all of SURG's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SurgePays investors own include Agilent Technologies (A), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Celldex Therapeutics (CLDX), Genocea Biosciences (GNCA), GTX (GTXI), Idera Pharmaceuticals (IDRA), Microbot Medical (MBOT), Progenics Pharmaceuticals (PGNX) and Rigel Pharmaceuticals (RIGL).

SurgePays trades on the NASDAQ under the ticker symbol "SURG."

Shares of SURG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SURG stock can currently be purchased for approximately $0.12.

SurgePays employs 31 workers across the globe.

The official website for SurgePays is www.surgeholdings.com.

SurgePays is headquartered at 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States.

SurgePays' mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The medical equipment provider can be reached via phone at (901) 302-9587.